Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
7.57
+1.54 (25.54%)
Nov 21, 2024, 3:50 PM EST - Market open
Omeros Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
198
Market Cap
438.68M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cross Country Healthcare | 1.45B |
Ginkgo Bioworks Holdings | 217.95M |
Kamada | 158.38M |
Codexis | 64.45M |
Alector | 61.51M |
AVITA Medical | 60.04M |
MaxCyte | 45.60M |
XOMA Royalty | 21.61M |
OMER News
- 6 hours ago - Omeros Corporation Provides Update on Progress Toward BLA Resubmission - Business Wire
- 7 days ago - Omeros Corporation (OMER) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Omeros Corporation Reports Third Quarter 2024 Financial Results - Business Wire
- 9 days ago - Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024 - Business Wire
- 4 weeks ago - FDA Grants Rare Pediatric Disease Designation to Omeros' MASP-3 Inhibitor Zaltenibart for Treatment of C3 Glomerulopathy - Business Wire
- 3 months ago - Omeros Corporation (OMER) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Omeros Corporation Reports Second Quarter 2024 Financial Results - Business Wire
- 3 months ago - Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024 - Business Wire